FDA Adverse Event Death Summary report: N

PROMUS ELEMENT? PLUS

MDR report key: 3950959 · Received July 22, 2014

Report

Report Number
2134265-2014-04269
Event Type
Death
Date Received
July 22, 2014
Date of Event
January 20, 2014
Report Date
June 26, 2014
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P110010
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT DEVICE EVALUATED BY MANUFACTURER - DEVICE NOT RETURNED THEREFORE ANALYSIS OF COMPLAINT DEVICE COULD NOT BE PERFORMED. THE BATCH NUMBER IS UNKNOWN AND THE MANUFACTURING RECORDS FOR THE COMPLAINT DEVICE COULD NOT BE REVIEWED. THE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED WITHIN THE DFU. (B)(4).

Description of Event or Problem · 1

(B)(4). SAME CASE AS MFR ID # 2134265-2014-04268. IT WAS REPORTED THAT FOLLOWING A PERCUTANEOUS CORONARY INTERVENTION, THE PATIENT EXPIRED. IN (B)(6) 2013, THE PATIENT PRESENTED WITH STABLE ANGINA. THE 2.5X30MM, 90% STENOSED, ECCENTRICALLY SHAPED, DE NOVO, TYPE C TARGET LESION WAS LOCATED IN THE SEVERELY CALCIFIED PROXIMAL CIRCUMFLEX (LCX) ARTERY. THE LESION WAS PRE-DILATED AND THE 2.25X32MM PROMUS ELEMENT PLUS STENT WAS DEPLOYED AT 12 ATMS. THE DEPLOYED STENT WAS POST-DILATED RESULTING IN TIMI 3 FLOW AND 0% RESIDUAL STENOSIS. IT WAS ALSO NOTED ANOTHER UNKNOWN PROMUS ELEMENT STENT WAS DEPLOYED DURING THE SAME PROCEDURE. THE PATIENT WAS DISCHARGED TWO DAYS LATER ON ASPIRIN AND PLAVIX. IN (B)(6) 2014, THE PATIENT EXPIRED. THE CAUSE OF DEATH IS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
429133 PROMUS ELEMENT? PLUS STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC - GALWAY H7493918432220

Patients

Seq Age Sex Outcome Treatment
1 54 YR Death